DMPKandLiver Fibrosis Modelof PharmaLegacy Laboratories (Shanghai) Co., Ltdis favored by the majority of customers love, We have established long-term cooperation with many partner, CDX Model,Respiratory Disease Modelfrom PharmaLegacymeet the needs of our customers. PharmaLegacystrength,abide by contract, keep faith, take quality and credit of contract,obtained the customer trust and praise.
PharmaLegacy Laboratories (Shanghai) Co., Ltd has been devoted to study the needs of PharmaLegacy industrial customers, ant tailored to customers demand and solutions. The advantage of PharmaLegacy lies not o
nly in the industry-leading technology and the elite professio
nal team, but also to provide excellent services in Pharmacodynamic e
valuation test platform,humanized animal model,antibody research and development servi,and the enthusiasm of positive innovation and faith of respect promise . Become a customer trusted Non-Human Primates Capability after sale integrated service providers, to help customers realize the business value of Non-Human Primates models, is PharmaLegacy unswerving mission and pursuit. Details: Non-human primates model (NHP) have closer phylogenetic relatio
nship to human and the disease targets in NHP models share high cross-reactivity to the human target specific biological molecules which do not react with rodent counterpart. PharmaLegacy has therefore developed and validated serials of NHP platforms, covering Inflammation/ Autoimmune Diseases, Bone/Orthopedics, Respiratory Disease, as well as Pharmacokinetics Profiling Assay to test pharmacological effects and mechanisms of candidate drugs especially for therapeutic mo
noclonal antibodies. Experiments involving non-human primates (NHPs) include toxicity testing for medical and non-medical substances; studies of infectious disease, such as HIV and hepatitis; neurological studies; behavior and cognition; reproduction; genetics; and xenotransplantation. Around 65,000 NHPs are used every year in the United States, and around 7,000 across the European Unio
n. Most of the NHPs used are one of three species of macaques, accounting for 79% of all primates used in research in the UK, and 63% of all federally funded research grants for projects using primates in the U.S. Lesser numbers of marmosets, tamarins, spider monkeys, owl monkeys, vervet monkeys, squirrel monkeys, and baboons are used in the UK and the US. Great Apes have not been used in the UK since a Government policy ban in 1998.
With the purpose of Quality first, service is paramount in PharmaLegacy, our strict product quality co
ntrol system ensures that Respiratory Disease Model,Humanized mouse modelx2a3868en and other products of high quality and stability. We have a first-class laboratory equipment and a highly experienced professio
nal and technical team. In the future, we will co
ntinue to work hard and get win-win cooperation for a better tomorrow! For more information, please visit the official website: www.pharmalegacy.com